Nephrocare IPO Details Today : Nephrocare IPO Details Today is Open on 28 June 2024 and Close on 2 July 2024. Nephrocare IPO to Raise 45,84,000 shares (Approx ₹41.26 Cr) via IPO. The Fresh issue of 45,84,000 shares (Approx ₹41.26 Cr).
Nephro Care was founded in the year 2014 by Dr. Pratim Sengupta in Kolkata with an object of providing comprehensive medical Services for renal patients. As on date, Nephro Care is a one stop treatment centre based in Kolkata that offers a wide range of clinical and lifestyle solutions and services and renalinsufficiency treatment to patients.
The treatment framework covers the entire range of lifestyle, physiological and spiritual aspects of wellness. The operations of Nephro Care are supported by a pool of expert Doctors, experienced and well-trained paramedical professionals and a skilled management team.
The entire team at Nephro Care is supported by sufficient clinical and investigative infrastructure. At Nephro Care treatment regimes are planned and practiced on the basis of core scientific understanding, transparency and ethics. We are committed to providing the best medical care at an affordable cost to all our local, national and international patients.
Our vision is to reach out to the masses through a holistic approach combining modern medicine with time tested yogic wisdom to touch the lives of one million kidney disease patients across the country by leveraging our hub-and-spoke model. Our clinics are equipped with technologically advanced equipment and diagnostic instruments. We have a wide spec of diagnostic facilities to provide our doctors freedom to explore all diagnostic possibilities and offer our patients a better service and care under one roof and to also ensure optimum clinical outcomes.
We have recently signed an agreement to take on lease an existing 60 bedded hospital at Madhyamgram, Kolkata and have embarked on a project to convert the same into a 100 bedded multi-speciality hospital and a part of the IPO proceeds is proposed to be utilised for the said purpose. At present, Nephro Care
offers the following services at our clinics
1. Inhouse Dialysis Unit.
2. Outpatient Services in areas of Nephrology, Diabetology, Cardiology, Ophthalmology and Neurology.
3. NABL accredited inhouse Pathology.
4. Inhouse Pharmacy.
5. Advance diagnostic facilities.
6. Renal Nutrition department.
7. Home Care.
8. Mukti (Lifestyle Support Program).
9. Home Dialysis.
Nephrocare IPO Date & Price Band Details
| IPO Open Date | 28 June 2024 |
|---|---|
| IPO Close Date | 2 July 2024 |
| IPO Size | 45,84,000 shares (Approx ₹41.26 Cr) |
| Fresh Issue | 45,84,000 shares (Approx ₹41.26 Cr) |
| Lot Size | 1600 Shares |
| IPO Face Value | ₹10 Per Equity Share" |
| IPO Price Band | ₹85 to ₹90 Per Every Share |
| IPO Listing On | NSE SME |
| IPO Retail Quota | 35% |
| IPO QIB Quota | 50% |
| IPO NII Quota | 15% |
| DRHP Draft | Click Here |
| Anchor Investor | Click Here |
Nephrocare IPO Market Lot Details
| Application | Lot Size | Shares | Amount |
|---|---|---|---|
| Retail Minimum | 1 | 1600 | ₹144,000 |
| Retail Maximum | 1 | 1600 | ₹144,000 |
| S-HNI Minimum | 2 | 3200 | ₹288,000 |
Object of the Issue
- Setting up of Multi Speciality Hospital in the name of “Vivacity Multi Specialty Hospital” (unit of Nephro Care) at Kolkata (Madhyamgaram), West Bengal; and
- General Corporate Expenses.
Nephrocare IPO Allotment & Listings (Details)
| IPO Open Date | 28 June 2024 |
|---|---|
| IPO Close Date | 2 July 2024 |
| Basis of Allotment | 3 July 2024 |
| Refunds | 4 July 2024 |
| Credit to Demat Account | 4 July 2024 |
| IPO Listing Date | 5 July 2024 |
Nephrocare Financial Reports
| ₹ in Crores | |||
|---|---|---|---|
| Year | Revenue | Expense | PAT |
| Dec 2023 | ₹19.90 | ₹15.30 | ₹3.40 |
| 2023 | ₹17.10 | ₹14.38 | ₹1.94 |
| 2022 | ₹3.43 | ₹3.43 | ₹00.0 |
| 2021 | ₹1.83 | ₹1.71 | ₹0.08 |
Our Company Promoters
- Dr. Pratim Sengupta
Qualitative Factors
- We bridge the gap between day care and tertiary care services by addressing unmet needs through a blend of modern medical science and time tested yogic wisdom for overall wellbeing of the patients
- Our technology backbone is robust and supports consistent improvements in the quality and efficiency of our service delivery.
- Track record of operating and financial performance and growth
- Professional management and experienced leadership
- Investment in infrastructure, processes and clinical services delivery framework, affordability resulting in a strong value proposition for stakeholders.
Nephrocare Company Contact Details
Flat No-1JC-18, 5th Floor Sec-III, Salt lake Kolkata,
Bidhan Nagar Sai Complex, North 24 Parganas -700098 West
Bengal, India
Telephone: +91 8017010197
Facsimile: Not Applicable
E-mail: cs@nephrocareindia.com
Investor grievance id: investor@nephrocareindia.com
Website: www.nephrocareindia.com
Nephrocare IPO Registrar
1st Floor, Bharat Tin Works Building, Opp. Vasant Oasis,
Makwana Road, Marol, Andheri East,
Mumbai – 400 059, Maharashtra, India.
Tel: +91 +91-22-6263 8200
E-mail: ipo@bigshareonline.com
Website: www.bigshareonline.com
Contact Person: Mr. Vinayak Morbole
1 thought on “Nephrocare IPO details Date, Price, GMP, Review”